Suppr超能文献

AST/ALT(De Ritis)比值对局限性肾细胞癌患者生存的影响及其与肿瘤组织病理学变量的关系。

The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.

机构信息

Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey.

出版信息

Int Braz J Urol. 2018 Mar-Apr;44(2):288-295. doi: 10.1590/S1677-5538.IBJU.2017.0173.

Abstract

PURPOSE

To assess the relationship between De Ritis (aspartate aminotransaminase [AST]/Alanine aminotransaminase [ALT]) ratio and pathological variables and whether it is an independent prognostic factor.

MATERIALS AND METHODS

We analyzed 298 consecutive patients who underwent radical or partial nephrectomy for non-metastatic renal cell carcinoma (RCC) between 2006 and 2015. The association between De Ritis ratio and pathological variables including tumor size, presence of renal vein invasion, vena cava invasion, renal capsule infiltration, Gerota fascia invasion, renal sinus involvement, renal pelvic invasion, angiolymphatic invasion, adrenal gland involvement, lymph node involvement, tumor necrosis, and Fuhrman's grade was tested. Multivariable Cox analysis was performed to evaluate the impact of this ratio on overall survival and cancer-specific survival.

RESULTS

An increased preoperative De Ritis ratio was significantly associated with renal vein invasion, renal capsule infiltration and renal pelvis involvement (p<0.05) in non-metastatic RCC. On multivariate analysis we found that tumor size, Fuhrman grade and lymph node involvement were independent prognostic factors for cancerspecific survival. AST/ALT ratio had no influence on the risk of overall and cancerspecific survival.

CONCLUSION

An increased preoperative AST/ALT ratio had a significant association with renal vein invasion, renal capsule infiltration and renal pelvis involvement in patients with non-metastatic RCC. However, it does not appear to be an independent prognostic marker in non-metastatic RCC.

摘要

目的

评估 De Ritis(天冬氨酸氨基转移酶 [AST]/丙氨酸氨基转移酶 [ALT])比值与病理变量之间的关系,并探讨其是否为独立的预后因素。

材料与方法

我们分析了 2006 年至 2015 年间 298 例接受根治性或部分肾切除术的非转移性肾细胞癌(RCC)患者的资料。检验 De Ritis 比值与肿瘤大小、肾静脉侵犯、腔静脉侵犯、肾包膜浸润、Gerota 筋膜侵犯、肾窦累及、肾盂侵犯、血管淋巴管侵犯、肾上腺侵犯、淋巴结侵犯、肿瘤坏死和 Fuhrman 分级等病理变量之间的相关性。采用多变量 Cox 分析评估该比值对总生存和癌症特异性生存的影响。

结果

术前 De Ritis 比值升高与非转移性 RCC 的肾静脉侵犯、肾包膜浸润和肾盂侵犯显著相关(p<0.05)。多变量分析发现,肿瘤大小、Fuhrman 分级和淋巴结侵犯是癌症特异性生存的独立预后因素。AST/ALT 比值对总生存和癌症特异性生存的风险无影响。

结论

术前 AST/ALT 比值升高与非转移性 RCC 的肾静脉侵犯、肾包膜浸润和肾盂侵犯显著相关。然而,其似乎不是非转移性 RCC 的独立预后标志物。

相似文献

引用本文的文献

本文引用的文献

1
Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.转氨酶活性可预测头颈癌患者的生存率。
PLoS One. 2016 Oct 12;11(10):e0164057. doi: 10.1371/journal.pone.0164057. eCollection 2016.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验